News and Events

CIRM’s Blog: The Stem Cellar

RSS The Stem Cellar
  • Genascence discusses gene therapy for knee osteoarthritis July 1, 2026
    Knee joint pain rarely gets counted among major public‑health burdens. Yet it affects more than 3 million Californians and 34 million people across the U.S., with both massive economic and health consequences. Costly Impact In California alone, the cost of knee replacement surgeries exceeds $8 billion annually, according to Thomas Chalberg, PhD, founder and CEO […]
  • Funding Available to Create Software to Integrate Regenerative Medicine Data June 26, 2026
    Scientific breakthroughs are built on insights from good data, but sometimes those breakthroughs are hidden under an ocean of too much of it.   Integrating data Recently the California Institute for Regenerative Medicine (CIRM) approved a new kind of investment. A new infrastructure award aims to create tools to make sense of the massive, complex biological datasets produced through CIRM-funded research. The program would fund the creation of new […]
  • Progress on Sickle Cell Disease Treatments  June 19, 2026
    Only three years ago, the FDA approved the first gene therapies for sickle cell disease (Lyfgenia and Casvegy), historic breakthroughs decades in the making. Yet on World Sickle Cell Awareness Day this year, the reality is that high cost, limited availability, and complex logistics keep these treatments out of reach for most people who need them.   Yet these breakthroughs offer tremendous hope. For many years, the […]

Subscribe to Receive CIRM News and Updates

View our Brand Assets and Multimedia Resources